Drug-responsive participants will be defined as having clinically documented partial seizures with consistent EEG evidence as defined by the 1981 International Classification of Epileptic Seizures responsive to standard antiepileptic treatment for at least three months prior to enrolling in this study This criterion will be established by preliminary screening in the NINDS Clinical Epilepsy Section outpatient clinic under protocol 01-N-0139 and if necessary inpatient video-EEG monitoring Seizure focus localization will be determined by standard clinical neurophysiologic and imaging studies 